Artificial Intelligence for Comprehensive Diagnostics, Examinations in Acute Coronary Syndromes
August 29th 2023Pharmacists can actively engage in the implementation of the Comprehensive Diagnostics and Examinations in Acute Coronary Syndromes pathway within the hospital or health care system.
Read More
Clinical Overview: Lecanemab for the Treatment of Alzheimer Disease
January 30th 2023Promising results for lecanemab's efficacy in patients with mild cognitive impairment or mild dementia associated with Alzheimer disease were accompanied by reports of adverse effects associated with treatment.
Read More